EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer

Idris Er, Asiye Busra Boz Er iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Idris Er und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey. Hauptthemen laut MEDLINE: Hedgehog Proteins, Drug Resistance, Neoplasm, Trastuzumab, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of National Education-TURKEY.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HER2 overexpression occurs in 20–30% of breast cancers and is associated with poor prognosis. Trastuzumab is a standard treatment for HER2-positive breast cancer; however, resistance develops in approximately 50% of patients within a year. The Hedgehog (Hh) signalling pathway, known for its role in maintaining stemness in various cancers, may contribute to trastuzumab resistance in HER2-positive breast cancer. This study aimed to investigate the role of Hedgehog signalling in maintaining stemness and contributing to trastuzumab resistance in HER2-positive breast cancer cell lines. Trastuzumab-resistant HER2-positive breast cancer cell lines, SKBR3 and HCC1954, were developed through continuous trastuzumab exposure. Cells were treated with GANT61 (Hh inhibitor, IC50:10 µM) or SAG21K (Hh activator, IC50:100 nM) for 24 h to evaluate the Hedgehog signalling response. Stemness marker expression (Nanog, Sox2, Bmi1, Oct4) was measured using qRT-PCR. The combination index (CI) of GANT61 with trastuzumab was calculated using CompuSyn software (version 1.0) to identify synergistic doses (CI < 1). The synergistic concentrations’ impact on stemness markers was assessed. Data were analysed using two-way ANOVA and Tukey’s post hoc test (p < 0.05). Trastuzumab-resistant cells exhibited increased Hedgehog signalling activity. Treatment with GANT61 significantly downregulated stemness marker expression, while SAG21K treatment led to their upregulation in both SKBR3-R and HCC1954-R cells. The combination of GANT61 and trastuzumab demonstrated a synergistic effect, markedly reducing the expression of stemness markers. These findings indicate that Hedgehog signalling plays a pivotal role in maintaining stemness in trastuzumab-resistant cells, and that the inhibition of this pathway may prevent tumour progression. Hedgehog signalling is crucial in regulating stemness in trastuzumab-resistant HER2-positive breast cancer. Targeting this pathway could overcome resistance and enhance trastuzumab efficacy. Further studies should explore the clinical potential of Hedgehog inhibitors in combination therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hedgehog ProteinsDrug Resistance, NeoplasmTrastuzumabBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesSignal TransductionNeoplastic Stem CellsHumansFemaleCell Line, TumorGene Expression Regulation, NeoplasticPyridinesPyrimidines

Stichwörter der Autor:innen

breast cancerhedgehogstemness

Substanzen

Hedgehog ProteinsTrastuzumabErb-b2 Receptor Tyrosine KinasesPyridinesPyrimidinesERBB2 protein, humanGANT 61

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Turkey.

ORCID-Profile: Asiye Busra Boz Er

Förderung

  • Ministry of National Education-TURKEY

Zitieren

APA

Er, I., & Boz Er, A. B. (2024). Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212102

Vancouver

Er I, Boz Er AB. Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212102

BibTeX
@article{Er2024,
  author = {Er, Idris and Boz Er, Asiye Busra},
  title = {Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212102}
}
Kostenlos starten →